Even with a health insurance policy, many Indians face large out-of-pocket medical bills due to specific clauses and rising healthcare costs. As medical inflation climbs by 12–14% annually, insurers are tightening terms, making it vital for policyholders to understand sub-limits and co-pays before the expected IRDAI reforms arrive later in 2026.
Many Indian health insurance policyholders discover that owning a comprehensive plan does not guarantee total coverage during a medical emergency. While premiums are often the primary focus for buyers, the actual financial protection depends on complex clauses that can lead to significant out-of-pocket expenses. With medical inflation currently running at an annual rate of 12–14%, insurers are increasingly using restrictive terms to manage rising claims, putting more financial burden on the customer.
One of the most common reasons for claim shortfalls is the restriction on room rent. Many policies link the cost of other hospital services—such as surgeon fees, ICU charges, and nursing costs—directly to the room category. If a patient chooses a room that exceeds their policy’s rent cap, the insurer may apply a pro-rata deduction, reducing the entire claim amount proportionally. This often results in a surprising bill, even if the treatment itself was covered under the sum insured.
Beyond room rent, features like co-payments and sub-limits remain standard in the industry. A co-payment requires the policyholder to pay a percentage of the total bill, which is frequently used to lower the overall premium. Additionally, sub-limits on specific procedures, such as cataract surgery or spinal treatments, cap the amount an insurer will pay, regardless of the actual cost incurred. These gaps in coverage often catch families unprepared, especially when the sum insured is not adjusted for the rapid increase in hospital charges.
The regulatory environment is currently shifting to address these transparency issues. The Insurance Regulatory and Development Authority of India (IRDAI) is actively working on comprehensive reforms, with a committee expected to submit recommendations by the end of 2026. These potential changes aim to introduce standardized treatment rates, a nationwide health claims exchange, and more transparent product designs to protect consumers. Until these reforms are implemented, the responsibility largely remains with the policyholder to scrutinize the fine print.
Another critical area for investors and policyholders to track is the 'Material Change' clause. This clause allows insurers to potentially revise terms, premiums, or coverage restrictions at the time of renewal if the policyholder develops a new health condition. Furthermore, minor omissions in medical history or discrepancies in hospital discharge summaries can lead to claim denials, even for long-term policies. While the moratorium period—usually after 60 months of continuous coverage—offers some protection against contestable claims, it does not cover cases where fraud or intentional non-disclosure is suspected.
As the insurance sector faces pressure to balance profitability with rising medical costs, the gap between the face value of a policy and the actual payout is likely to persist. For families, the key monitorable will be ensuring that the sum insured accounts for current inflation and that they are fully aware of any specific sub-limits or network hospital restrictions before a medical need arises.